{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:48:41Z","timestamp":1791388121534,"version":"4.3.3"},"reference-count":32,"publisher":"Galenos Yayinevi","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2021.2021.0607","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T14:40:07Z","timestamp":1641307207000},"page":"13-21","source":"Crossref","is-referenced-by-count":12,"title":["JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles"],"prefix":"10.4274","volume":"39","author":[{"given":"Hilal","family":"Hekimo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin  Fulya","family":"Toprak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sel\u00e7uk","family":"S\u00f6zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Liang C, Tian L, Liu Y, et al. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir. Eur J Med Chem. 2020;201:112527. doi:10.1016\/j.ejmech.2020.112527","DOI":"10.1016\/j.ejmech.2020.112527"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Eastman RT, Roth JS, Brimacombe KR, et al. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. ACS Cent Sci. 2020;6(5):672-683. doi:10.1021\/acscentsci.0c00489","DOI":"10.1021\/acscentsci.0c00489"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Arch Med Res. 2020;51(6):585-586. doi:10.1016\/j.arcmed.2020.05.001","DOI":"10.1016\/j.arcmed.2020.05.001"},{"key":"ref3","unstructured":"4. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Disponible en: https:\/\/covid19treatmentguidelines.nih.gov\/. Natl Inst Heal. 2020;2019:130. https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Sahakijpijarn S, Moon C, Koleng JJ, Christensen DJ, Williams RO. Development of remdesivir as a dry powder for inhalation by thin film freezing. Pharmaceutics. 2020;12(11):1-27. doi:10.3390\/pharmaceutics12111002","DOI":"10.3390\/pharmaceutics12111002"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Malin JJ, Su\u00e1rez I, Priesner V, F\u00e4tkenheuer G. Remdesivir against COVID-19 and Other Viral Diseases. Am Soc Microbiol. 2021;34(1):1-21. doi:https:\/\/doi.org\/10 .1128\/CMR.00162-20","DOI":"10.1128\/CMR.00162-20"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Sun D. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit. AAPS J. 2020;22(4). doi:10.1208\/s12248-020-00459-8","DOI":"10.1208\/s12248-020-00459-8"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Melo C de O, Rodrigues MS da S, da Silva MVS, et al. Preparation and characterization of spiro-acridine derivative and 2-hydroxypropyl-\u03b2-cyclodextrin inclusion complex. J Mol Struct. 2020;1222:128945. doi:10.1016\/j.molstruc.2020.128945","DOI":"10.1016\/j.molstruc.2020.128945"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Creteanu A, Pamfil D, Vasile C, et al. Study on the Role of the Inclusion Complexes with 2-Hydroxypropyl- \u03b2 -cyclodextrin for Oral Administration of Amiodarone. Int J Polym Sci. 2019;2019. doi:10.1155\/2019\/1695189","DOI":"10.1155\/2019\/1695189"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. YURTDA\u015e KIRIMLIO\u011eLU G. Host-guest inclusion complex of desloratadine with 2-(Hydroxy)propyl-\u03b2-cyclodextrin (hp-\u03b2-cd): Preparation, binding behaviors and dissolution properties. J Res Pharm. 2020;24(5):693-707. doi:10.35333\/jrp.2020.224","DOI":"10.35333\/jrp.2020.224"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of cyclodextrins and drug\/cyclodextrin complexes. Molecules. 2018;23(5):1-15. doi:10.3390\/molecules23051161","DOI":"10.3390\/molecules23051161"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Terauchi M, Tamura A, Yamaguchi S, Yui N. Enhanced cellular uptake and osteogenic differentiation efficiency of melatonin by inclusion complexation with 2-hydroxypropyl \u03b2-cyclodextrin. Int J Pharm. 2018;547(1-2):53-60. doi:10.1016\/j.ijpharm.2018.05.063","DOI":"10.1016\/j.ijpharm.2018.05.063"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Ghosh A, Biswas S, Ghosh T. Preparation and evaluation of silymarin \u03b2-cyclodextrin molecular inclusion complexes. J Young Pharm. 2011;3(3):205-210. doi:10.4103\/0975-1483.83759","DOI":"10.4103\/0975-1483.83759"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Chen J, Yao J, Ma Z, et al. Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition. J Liposome Res. 2017;27(1):21-31. doi:10.3109\/08982104.2016.1140184","DOI":"10.3109\/08982104.2016.1140184"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Ye W, Yao M, Dong Y, et al. Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition. Front Microbiol. 2020;11(June):1-9. doi:10.3389\/fmicb.2020.01105","DOI":"10.3389\/fmicb.2020.01105"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Ren Z, Xu Y, Lu Z, et al. Construction of a water-soluble and photostable rubropunctatin\/\u03b2-cyclodextrin drug carrier. RSC Adv. 2019;9(20):11396-11405. doi:10.1039\/c9ra00379g","DOI":"10.1039\/C9RA00379G"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Rassu G, Fancello S, Roldo M, et al. Investigation of cytotoxicity and cell uptake of cationic beta-cyclodextrins as valid tools in nasal delivery. Pharmaceutics. 2020;12(7):1-13. doi:10.3390\/pharmaceutics12070658","DOI":"10.3390\/pharmaceutics12070658"},{"key":"ref17","unstructured":"18. Patil JS, Kadam D V., Marapur SC, Kamalapur M V. Inclusion complex system; a novel technique to improve the solubility and bioavailability of poorly soluble drugs: A review. Int J Pharm Sci Rev Res. 2010;2(2):29-34."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Chouker MA, Abdallah H, Zeiz A, El-Dakdouki MH. Host-quest inclusion complex of quinoxaline-1,4-dioxide derivative with 2-hydroxypropyl-\u03b2-cyclodextrin: Preparation, characterization, and antibacterial activity. J Mol Struct. 2021;1235:130273. doi:10.1016\/j.molstruc.2021.130273","DOI":"10.1016\/j.molstruc.2021.130273"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Vukic MD, Vukovic NL, Popovic SL, et al. Effect of \u03b2-cyclodextrin encapsulation on cytotoxic activity of acetylshikonin against HCT-116 and MDA-MB-231 cancer cell lines. Saudi Pharm J. 2020;28(1):136-146. doi:10.1016\/j.jsps.2019.11.015","DOI":"10.1016\/j.jsps.2019.11.015"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Qiao X, Yang L, Hu X, et al. Characterization and evaluation of inclusion complexes between astaxanthin esters with different molecular structures and hydroxypropyl-\u03b2-cyclodextrin. Food Hydrocoll. 2021;110(5):106208. doi:10.1016\/j.foodhyd.2020.106208","DOI":"10.1016\/j.foodhyd.2020.106208"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Qudsiani K, Sutriyo, Rahmasari R. Polyamidoamine-Remdesivir Conjugate: Physical Stability and Cellular Uptake Enhancement. Biomed Pharmacol J. 2021;14(4):2073-2083. doi:10.13005\/bpj\/2304","DOI":"10.13005\/bpj\/2304"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Tambe A, Pandita N, Kharkar P, Sahu N. Encapsulation of boswellic acid with \u03b2- and hydroxypropyl-\u03b2-cyclodextrin: Synthesis, characterization, in vitro drug release and molecular modelling studies. J Mol Struct. 2018;1154:504-510. doi:10.1016\/j.molstruc.2017.10.061","DOI":"10.1016\/j.molstruc.2017.10.061"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Sadaquat H, Akhtar M. Comparative effects of \u03b2-cyclodextrin, HP-\u03b2-cyclodextrin and SBE7-\u03b2-cyclodextrin on the solubility and dissolution of docetaxel via inclusion complexation. J Incl Phenom Macrocycl Chem. 2020;96(3-4):333-351. doi:10.1007\/s10847-020-00977-0","DOI":"10.1007\/s10847-020-00977-0"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Menezes PP, Serafini MR, Quintans-J\u00fanior LJ, et al. Inclusion complex of (-)-linalool and \u03b2-cyclodextrin. J Therm Anal Calorim. 2014;115(3):2429-2437. doi:10.1007\/s10973-013-3367-x","DOI":"10.1007\/s10973-013-3367-x"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Yuan C, Liu B, Liu H. Characterization of hydroxypropyl-\u03b2-cyclodextrins with different substitution patterns via FTIR, GC-MS, and TG-DTA. Carbohydr Polym. 2015;118:36-40. doi:10.1016\/j.carbpol.2014.10.070","DOI":"10.1016\/j.carbpol.2014.10.070"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Celebioglu A, Uyar T. Metronidazole\/Hydroxypropyl-\u03b2-Cyclodextrin inclusion complex nanofibrous webs as fast-dissolving oral drug delivery system. Int J Pharm. 2019;572(August):118828. doi:10.1016\/j.ijpharm.2019.118828","DOI":"10.1016\/j.ijpharm.2019.118828"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Qiao X, Yang L, Hu X, et al. Food Hydrocolloids Characterization and evaluation of inclusion complexes between astaxanthin esters with different molecular structures and hydroxypropyl- \u03b2 -cyclodextrin. Food Hydrocoll. 2021;110(5):106208. doi:10.1016\/j.foodhyd.2020.106208","DOI":"10.1016\/j.foodhyd.2020.106208"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Kasapoglu-Calik M, Ozdemir M. Synthesis and controlled release of curcumin-\u03b2-cyclodextrin inclusion complex from nanocomposite poly(N-isopropylacrylamide\/sodium alginate) hydrogels. J Appl Polym Sci. 2019;136(21):1-11. doi:10.1002\/app.47554","DOI":"10.1002\/app.47554"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Ghosh R, Roy N, Saha S, et al. Synthesis and characterization of an industrially significant ionic liquid and its inclusion complex with \u03b2 -cyclodextrin and its soluble derivative for their advanced applications. Chem Phys Lett. 2021;769(February):138401. doi:10.1016\/j.cplett.2021.138401","DOI":"10.1016\/j.cplett.2021.138401"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Chu H, Chan JF-W, Yuen TT-T, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. The Lancet Microbe. 2020;1(1):e14-e23. doi:10.1016\/s2666-5247(20)30004-5","DOI":"10.1016\/S2666-5247(20)30004-5"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Kulkarni AD, Belgamwar VS. Inclusion complex of chrysin with sulfobutyl ether-\u03b2-cyclodextrin (Captisol\u00ae): Preparation, characterization, molecular modelling and in vitro anticancer activity. J Mol Struct. 2017;1128:563-571. doi:10.1016\/j.molstruc.2016.09.025","DOI":"10.1016\/j.molstruc.2016.09.025"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T07:26:35Z","timestamp":1654759595000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-57355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2,24]]}},"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2021.2021.0607","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]}}}